ScottTylerAaronsonMD
Psychiatry • Towson, MDAdjunct Professor, Psychiatry, University of Maryland School of Medicine Chief Science Officer, Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System
Dr. Aaronson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6501 N Charles St
Towson, MD 21204Phone+1 410-938-3125Fax+1 410-938-3111- Is this information wrong?
Summary
- Dr. Scott Aaronson is a psychiatrist in Towson, MD and is affiliated with Sheppard Pratt Health System. He received his medical degree from Harvard Medical School and has been in practice 36 years. His research covers novel treatments for difficult to treat mood and anxiety disorders and includes multiple studies with psychedelics as well as experimental neuromodulation techniques. He has more than 100 publications and over 3000 citings.
Education & Training
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1981 - 1985
Harvard Medical SchoolClass of 1981
Certifications & Licensure
MD State Medical License 2001 - 2024
MA State Medical License 1982 - 2001- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Treatment-Resistant Depression Registry Start of enrollment: 2006 Jan 01
- Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1) Start of enrollment: 2011 Sep 01
- Investigating tDCS as a Treatment for Unipolar and Bipolar Depression Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.Andrew van der Vaart, Harold A Sackeim, Scott T Aaronson> ;JAMA Psychiatry. 2024 Apr 10
- When to hold and when to fold: Early prediction of nonresponse to transcranial magnetic stimulation in major depressive disorder.Harold A Sackeim, Scott T Aaronson, Linda L Carpenter, Todd M Hutton, Kenneth Pages, Lindsay Lucas, Bing Chen> ;Brain Stimulation. 2024 Mar 6
- New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.Aaronson, S., Kozak, Z.> ;Med. 2024 Mar 8
- Join now to see all
Press Mentions
Why You Should Care Who Controls PsychedelicsMay 7th, 2021- Correction: COMPASS Pathways Establishes Centre of Excellence with Sheppard Pratt to Accelerate Research and Improve Patient Experience in Mental Health CareJanuary 8th, 2021
- Genomind Announces Major Industry-Leading HLA-A Test Innovation on Its Comprehensive Mental Health Pharmacogenetics (PGx) Test, Increasing Utility for Tens of Thousands of Clinicians and PatientsSeptember 10th, 2020
- Join now to see all
Hospital Affiliations
Sheppard PrattTowson, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
